In other clinical trials, NRF2 hyperactivation has been linked to the development of bone hypoplasia [58], hydronephrosis [59], esophagus, and forestomach hyperkeratosis [60], altered mitochondrial bioenergetics, hallmark features of type 1 diabetes, and accelerated aging [61]. Here, NFE2L2 is linked to Hyperkeratosis.